A detailed history of Victory Capital Management Inc transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Victory Capital Management Inc holds 201,306 shares of DVAX stock, worth $2.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
201,306
Previous 240,024 16.13%
Holding current value
$2.56 Million
Previous $2.7 Million 16.81%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$10.05 - $11.61 $389,115 - $449,515
-38,718 Reduced 16.13%
201,306 $2.24 Million
Q2 2024

Aug 05, 2024

SELL
$10.73 - $12.58 $658,049 - $771,506
-61,328 Reduced 20.35%
240,024 $2.7 Million
Q1 2024

May 03, 2024

BUY
$11.7 - $14.98 $50,696 - $64,908
4,333 Added 1.46%
301,352 $3.74 Million
Q4 2023

Feb 05, 2024

SELL
$13.09 - $14.98 $42,542 - $48,685
-3,250 Reduced 1.08%
297,019 $4.15 Million
Q3 2023

Nov 06, 2023

SELL
$12.64 - $14.99 $407,576 - $483,352
-32,245 Reduced 9.7%
300,269 $4.43 Million
Q2 2023

Jul 27, 2023

SELL
$9.85 - $13.17 $34,484 - $46,108
-3,501 Reduced 1.04%
332,514 $4.3 Million
Q1 2023

May 02, 2023

SELL
$9.44 - $11.88 $200,496 - $252,319
-21,239 Reduced 5.95%
336,015 $3.3 Million
Q4 2022

Feb 10, 2023

BUY
$10.27 - $13.29 $71,273 - $92,232
6,940 Added 1.98%
357,254 $3.8 Million
Q4 2022

Feb 09, 2023

SELL
$10.27 - $13.29 $258,177 - $334,097
-25,139 Reduced 6.7%
350,314 $3.73 Million
Q3 2022

Nov 02, 2022

SELL
$9.93 - $17.44 $321,275 - $564,253
-32,354 Reduced 7.93%
375,453 $3.92 Million
Q2 2022

Aug 01, 2022

BUY
$7.45 - $12.83 $1.87 Million - $3.22 Million
250,825 Added 159.78%
407,807 $5.13 Million
Q1 2022

May 04, 2022

SELL
$9.75 - $14.44 $1.97 Million - $2.92 Million
-202,079 Reduced 56.28%
156,982 $1.39 Million
Q4 2021

Feb 07, 2022

SELL
$13.17 - $20.94 $2.72 Million - $4.33 Million
-206,822 Reduced 36.55%
359,061 $5.05 Million
Q3 2021

Nov 02, 2021

BUY
$9.16 - $19.83 $1.18 Million - $2.55 Million
128,639 Added 29.42%
565,883 $10.9 Million
Q2 2021

Aug 03, 2021

SELL
$7.25 - $10.99 $155,679 - $235,988
-21,473 Reduced 4.68%
437,244 $4.31 Million
Q1 2021

May 04, 2021

SELL
$4.57 - $11.18 $195,500 - $478,269
-42,779 Reduced 8.53%
458,717 $4.51 Million
Q4 2020

Feb 01, 2021

SELL
$3.73 - $5.6 $542,912 - $815,096
-145,553 Reduced 22.49%
501,496 $2.23 Million
Q3 2020

Nov 09, 2020

BUY
$4.32 - $11.7 $2.1 Million - $5.69 Million
486,134 Added 302.11%
647,049 $2.8 Million
Q2 2020

Aug 07, 2020

BUY
$2.94 - $9.1 $437,683 - $1.35 Million
148,872 Added 1236.17%
160,915 $1.43 Million
Q1 2020

May 04, 2020

SELL
$2.27 - $6.2 $5,793 - $15,822
-2,552 Reduced 17.49%
12,043 $43,000
Q4 2019

Feb 06, 2020

BUY
$3.46 - $6.93 $10,393 - $20,817
3,004 Added 25.92%
14,595 $83,000
Q4 2019

Feb 04, 2020

BUY
$3.46 - $6.93 $1,999 - $4,005
578 Added 5.25%
11,591 $59,000
Q3 2019

Nov 12, 2019

BUY
$2.69 - $4.85 $29,624 - $53,413
11,013 New
11,013 $39,000
Q2 2019

Aug 15, 2019

SELL
$3.65 - $7.89 $5,493 - $11,874
-1,505 Closed
0 $0
Q4 2018

Feb 05, 2019

SELL
$8.14 - $13.28 $2,336 - $3,811
-287 Reduced 16.02%
1,505 $14,000
Q3 2018

Nov 01, 2018

BUY
$11.85 - $16.0 $2,784 - $3,760
235 Added 15.09%
1,792 $22,000
Q2 2017

Aug 07, 2017

BUY
N/A
1,557
1,557 $15,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.61B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.